Nonopioid Analgesia After Labral Surgery

Launched by HENRY FORD HEALTH SYSTEM · Jan 30, 2019

Keywords

ClinConnect Summary

This clinical trial is studying different ways to manage pain after labral surgery, which is a procedure often done to repair certain shoulder injuries. The researchers want to find out if a nonopioid pain management approach (using medications that do not include narcotics) can control pain as effectively as the standard method, which typically includes opioid medications. The trial is looking for adults aged 18 and older who are scheduled for either their first labral surgery or a repeat surgery.

Participants in the trial will be randomly assigned to one of two groups: one will receive the nonopioid pain management plan, while the other will receive the usual opioid pain control. It’s important to note that individuals with certain medical conditions, such as allergies to specific pain medications, recent narcotic use, or certain gastrointestinal issues, may not be eligible to join. If you participate, you can expect to be monitored for pain levels after surgery and receive care tailored to your assigned treatment group. This study aims to find safer and more effective ways to manage pain after surgery, potentially reducing reliance on narcotics.

Gender

ALL

Eligibility criteria

• Eligibility Criteria:
• Inclusion Criteria:
• • All adult patients over age 18 and scheduled for a primary or revision labral surgery
• Exclusion Criteria:
• • Exclusion criteria will include patients with a medical history of known allergies or intolerance to allergies or intolerance to Celebrex, Tylenol, Neurontin, dexamethasone, tramadol, substantial alcohol or drug abuse, and pregnancy, history of narcotics within 6 months of surgery, renal impairment, peptic ulcer disease, GI bleeding. Secondary exclusion criterion is an intact rotator cuff